There’s a lot to each of us.
And we bring it all together – as one.

|   Location: Sydney, AU

Dr Michelle Deaker is a Founding & Managing Partner of OneVentures and has been primarily responsible for the foundation of OneVentures firm and capital raisings of OneVentures Funds. The firm now has over $700M in funds under management. Michelle serves on the investment committee of OneVentures three main Funds, leads the technology practice within the firm and is responsible for investor relations managing the supervisory boards of OneVentures funds.

Michelle has over 20 years experience in the development of high growth technology companies in Australia and the US, has served on the boards of large and small listed and unlisted companies and has a strong background in Australian R&D and expertise in global business expansion. She has negotiated technology transfer contracts with research institutions; established financing syndicates with Australian, Asian and US investors; chaired the boards of several high growth companies; supported early breakthrough commercial contracts; leveraged her extensive networks for the benefit of OneVentures companies; and negotiated both financing and exit transactions.

Michelle established OneVentures in late 2006, coming into the venture capital industry as a successful IT industry business owner, entrepreneur and subsequently angel investor. The Company she founded in 1999, E Com Industries (www.giftvouchers.com), became the leading prepaid card and electronic voucher provider in Australia, servicing over 100 major retail brands including Coles Myer and Woolworths, managing $700M in Australian retail liability and eventually expanding operations into the United Kingdom, South Africa and New Zealand. E Com was acquired by UK publicly listed company, Retail Decisions, in 2005, in a transaction returning to investors 4.6x capital and an average IRR of 70%. Notably, E Com industries was one of only a handful of Australian companies that successfully migrated the dotcom boom and crash through to a successful outcome for investors. Prior to E Com Industries, Michelle established IT enterprise business, Networks Beyond 2000.

Michelle holds a Bachelor of Science (Honours 1st class), Master of Science and a PhD (Applied Science). She is a member of the Australian Institute of Company Directors and Chief Executive Women (CEW).

|   BSc(Hons), MSc, PhD 

|   Healthcare  

|   Location: Sydney, AU

Paul is a Founding Partner of OneVentures, leading the Healthcare and Biotechnology practice. He serves as Fund Lead and Chair of the Investment Committee for Healthcare Fund III and is a voting member of the Investment Committees for Funds I, II, III and V.

With over 30 years of experience in biomedical innovation, Paul provides strategic guidance to portfolio companies. He is Chair of Vaxxas and a Non-Executive Director for BiVACOR and Prota Therapeutics. Previously, he served on the boards of Hatchtech (Chair, licensed to NYSE: DRL), CharmHealth (acquired by ASX: CGL), Clinical Genomics (Enterix acquired by 3TM), Blade and Find Me.

As co-founder of Gemini Genomics (Nasdaq: GMNI), he led one of the UK’s largest biotech IPOs (US$250M valuation) before its merger with Sequenom (Nasdaq: SQNM). Earlier in his career, he co-founded Agamatrix, a bio-sensing medical device company operating in the US and Southeast Asia as well as Atomera (Nasdaq: ATMR). As CEO of Orchid Cellmark (Nasdaq: ORCH), he drove a tenfold valuation increase and significant revenue growth.

Paul began his career as a researcher and endocrinologist at St Vincent’s Hospital Sydney before transitioning into biotechnology. In the US, he held executive roles in leading biotech and medical companies driving the growth of several industry leaders.

He has authored over 100 publications in leading journals and is a Non-Executive Director at the Garvan Institute of Medical Research, a member of the UNSW Medicine Dean’s Advisory Group and serves on the Advisory Board of the Australian Government’s Australia’s Economic Accelerator (AEA) program.

Paul holds medical degrees from UNSW and is a Fellow of the Royal Australasian College of Physicians.

|   MBBS(Hons), MD, FRACP 

|   BSc(Hons), AMCT   |   Location: Sydney, AU

Nick Gainsley is a Partner at OneVentures and leads the Growth Credit practice of the firm. Nick is committed to ensuring that companies in Australia can access alternative forms of capital by bringing his extensive global experience with debt and financing to the local market.

As one of the leading pioneers of Growth Credit in Australia, Nick is in high demand as a keynote speaker and conference panellist. He regularly appears in the media as an expert on Growth Credit and alternative debt financing. For media and speaking enquiries, please contact us.

Nick is a keen skier and loves to travel the world – with his young family in tow. Being a Brit he used to long haul and is looking forward to the direct Sydney-London flight in the coming years. He loves to ski steep off-piste terrain however he’s been forced to recalibrate to “family friendly” black runs.

Nick brings over 15 years of debt experience both in direct lending and advisory, in Europe and Australia. He has nearly 10 years of Growth Credit experience having led investments to over 100 high growth technology companies across 11 countries.

At OneVentures, he serves on the Investment Committee of the 1V Venture Credit Fund IV and the OneVentures Growth Fund V.

Prior to joining OneVentures in May 2019, Nick was based in the UK and was a Principal at Kreos Capital (now part of Blackrock), Europe’s largest growth debt fund. His experience there covered deal origination, execution and portfolio management for a significant number of transactions across European markets. He has wider sector experience across technology sub-sectors including FinTech, software, cyber security, hardware, e-commerce/DTC, AdTech and life science, investing in both private and public companies.

Prior to this Nick was a Manager at KPMG in London within its Debt Advisory team, where he was involved in managing and advising on a range of debt transactions from mid-market to large cap. Transaction experience covered leveraged finance, corporate refinancing, capital market issuance and strategic financing advice.

Nick is currently a mentor at Stone & Chalk and the AIC women mentorship programme.

|   BAgrSc(Hons), M.P.S, GAICD   |   Location: Brisbane, AU

Sarah is responsible for sourcing life sciences companies and actively shaping their future. She applies her global executional experience and entrepreneurial passion to nurture their success. Her enterprise level leadership experience has been forged over 20 years in a wide spectrum of organisations, including start-up, private companies, ASX and NASDAQ-listed companies, a multi-national pharmaceutical company and university research organisations.

Prior to OneVentures, she was the Asian Business Development lead for Shire Pharmaceuticals (now Takeda), a global specialty pharmaceutical company. Sarah identified technologies and developed collaborations across Japan, Korea, Australia, New Zealand, Singapore and Taiwan including playing a key role in sourcing the $300M Fibrotech deal announced in 2015.

Sarah has held senior management roles at Progen Pharmaceuticals, The University of Queensland’s QAAFI institute, Beef CRC and Pyxis Genomics. From 2011-2017 she led the development of the new UQ QAAFI research institute from 32 people to 450 people and a financially profitable position within 5 years. This included leading the negotiation of a complex $70+M staff transfer and research agreement for QAAFI between the University of Queensland and the Queensland Government. In 2012, Sarah spearheaded the IP asset assignment and company wind-up of 20 year $168M Beef Co-operative Research Centre, involving five universities across five state jurisdictions, MLA, CSIRO and Meat and Lamb NZ and pastoral companies. At Progen Pharmaceuticals, Sarah worked collaboratively with the CEO and CFO over several years to secure a total financing of ~$125M via five capital raisings for oncology drug development, and in 2008 led the $22M acquisition of an oncology drug discovery company.

Sarah has a strong understanding of the pharmaceutical, medical device and healthcare industries including key inflexion points, intellectual property, regulatory and reimbursement strategies, business development options and strategic product management. She combines this with the ability to understand scientific information quickly and build credibility with technical experts and industry players. She is passionate about commercialising new technologies, and has the strategic vision and positive energy to deliver under tight timeframes in a team environment.

Sarah is a graduate of the Australian Institute of Company Directors (GAICD) and currently holds directorships with Kira Biotech, QAAFI Advisory Board and Life Sciences Queensland. She holds Bachelor level science qualifications from the University of Queensland and a Masters from Cornell University and has completed a postgraduate course at Harvard Business School focusing on negotiation and decision making.

|   MCom, USYD BCom, USYD  |   Location: Sydney, AU

Bevin leads OneVentures technology investment strategy for Fund V and Fund VII and serves on the investment committees of both funds. With over 20 years of experience spanning technology investing, corporate advisory, M&A and capital markets, Bevin has a proven passion for driving growth in emerging technology companies through both organic and inorganic strategies while emphasising operational excellence.

Before joining OneVentures, Bevin was a Partner at Bailador Technology Investments Limited, an ASX-listed technology growth fund. In his role, Bevin was responsible for sourcing and executing growth-stage technology investments across Australia and New Zealand. He also served on the investment committee and led the investor relations function, overseeing fundraising initiatives. During his 5+ years, Bailador successfully delivered nine cash realisations, returning approximately $250 million at an average 3.1x CoC and 25%IRR.

Bevin played a key role in managing Bailador’s investments, including Rezdy, a global leader in booking software for the tours and activities sector, where he led its merger with US-based Checkfront and Europe’s Regiondo to form the world’s largest independent booking software business, RC TopCo. He oversaw Bailador’s investment in Standard Media Index, a global advertising spend analytics platform and led the firm’s exit to US private equity group, GTCR. He also played a key role in the firm’s $1.6 billion IPO of Australian Unicorn SiteMinder on the ASX and the firm’s $20 million investment in digital healthcare platform Updoc. He served on the board of Standard Media Index and was a board observer for Rezdy and RC TopCo.

Prior to Bailador, Bevin was the Head of M&A and Investor Relations at ASX-listed Catapult Group, a global leader in the provision of elite athlete tracking and performance analytics. He led the firm’s M&A strategy, driving numerous major acquisitions that significantly increased Catapult’s financial scale, extended its technological reach and diversified its market presence. He also directed all capital-raising efforts, securing over $150 million in debt and equity financing to support the firm’s growth strategy.

Bevin started his career in Economics Research at Macquarie Group while completing his tertiary studies. He then joined Deloitte Corporate Finance Australia’s graduate program, working in corporate advisory, valuations and transaction services. His investing career began at Helmsec Global Capital, where he co-founded Endocoal Limited, which was acquired by U&D Mining in 2012, and led over $500 million in M&A and capital markets transactions for early-stage companies. Bevin also gained valuable experience working in the investment banking division at the Royal Bank of Scotland for over four years before moving full-time into technology sector investing.

Bevin holds a Bachelor of Commerce and Master of Commerce from the University of Sydney. Bevin is a Member of the Australian Institute of Company Directors.

|   Growth Equity

|   Location: Sydney, AU

|   Location: Sydney, AU

Matt is a Partner and COO at OneVentures, where he leads legal, compliance, corporate finance, investor relations and marketing functions.

As General Counsel, Company Secretary and a Responsible Manager, Matt ensures regulatory excellence and robust governance. Matt also drives ESG practices across the portfolio, supporting founders and investors by implementing effective structures, aligning with industry standards and advancing sustainability goals.

With over 20 years of legal experience in financial services, he has held senior leadership roles both locally and internationally, including General Counsel & Company Secretary at Eclipx Group and Head of Legal, Compliance and Company Secretary at ING Bank Australia. His early career includes positions at Corrs Chambers Westgarth, Perpetual and Pitcher Partners.

Matt holds a Bachelor of Laws (LLB) and a Bachelor of Business (BBus) in Banking and Finance from QUT. Admitted to the Supreme Court of NSW and the High Court of Australia, he is also a Chartered Secretary and Public Notary.

|   LLB BBus Banking & Finance 

|   Location: Brisbane, AU

|   BSc(Hons), MBA, GAICD 

|   Healthcare  

|   Location: Sydney, AU

John is a Venture Partner at OneVentures supporting the Healthcare team and portfolio companies with strategic guidance and operational expertise.

He has over 20 years of global experience in life sciences spanning operational leadership, venture capital and investment banking.

Previously, John was CFO of Elastagen, an Australian medical device company, where he led fundraising. He also played a key role in the international expansion of the company’s clinical studies in the UK and in the company’s acquisition by Allergan. Elastagen was recognised as the Australian Investment Council’s Best Venture Capital Investment of 2018. Post-acquisition he oversaw the integration of Elastagen’s clinical programs as Director of R&D and later as a consultant.

Prior to his tenure at Elastagen, John spent eight years at Nomura Phase4 Ventures in London investing in early to mid-stage life science companies across the US and Europe. He began his career at Morgan Stanley advising healthcare multinationals on capital raising, divestitures and acquisitions.

John holds a PhD and a BSc (Hons) in Biochemistry from Heriot-Watt University, completing the first year of his PhD at Dundee University. He is a recipient of the Watt Club Medal.

|   BSc(Hons), PhD

|   Healthcare

|   Location: Melbourne, AU

Jeannie is a Venture Partner at OneVentures, supporting healthcare portfolio company operations and strategic initiatives.

She serves on the board of ImmVirX (deal lead), BiVACOR Pty Ltd, BiVACOR Australia and Hatchtech, and has previously held board roles with BiVACOR Inc (as Chair and Director).

A biopharmaceutical and medical device leader with 20+ years of global experience, Jeannie has held senior executive and advisory roles in Australia and the US. Her expertise includes business development, strategic partnerships, and operational leadership across research, clinical trials, and commercial management.

In the US, she led global business development, licensing medical device technologies to major pharmaceutical companies and securing milestone and royalty payments. Her career includes roles with organisations such as Bristol-Myers Squibb, Mayne Pharma, CSL, and Enable Injections.

Jeannie holds a PhD and a Bachelor of Science (Hons) in Immunology from Monash University and a Diploma of Marketing from the Melbourne Business School. She currently serves as a Non-Executive Director for ASX-NASDAQ listed Immuron and ASX-listed Argenica.

|   BSc(Hons), PhD   

|   Growth Equity 

|   Location: Sydney, AU

Amrita is a Growth Equity Venture Partner at OneVentures, supporting our technology portfolio companies with her operations and strategy expertise.

An experienced C-suite executive and Non-Executive Director, Amrita brings extensive expertise in strategy, operations, manufacturing, pricing, sales, and marketing across technology and healthtech companies.

Her leadership roles include serving as Co-CEO of SomnoMed (ASX: SOM) and as Chief Operating and Marketing Officer at eBay Australia.

Amrita is a Non-Executive Director at Audinate (ASX: AD8) and Genea, and has worked as a management consultant.

She holds an MBA from Harvard Business School and a Bachelor of Engineering (Biomedical).

|  BE(Hons), MBA

|   BComm, CFA, CA   |   Location: Melbourne, AU

|   Growth Credit & Growth Equity

Justine is an Investment Director at OneVentures and is responsible for the new Victorian Growth Fund, focusing on providing Venture Credit to Victoria’s most exciting start ups.

Justine returned to Australia in late 2021, after 3 years working in Tokyo advising life science and beauty companies on cross border M&A. She brings her wealth of knowledge in M&A Advisory, her passion for entrepreurship and her experience with capital raising to the Venture Credit team. She is a valued advisor and is driving the awareness and adoption of Venture Credit (also known as venture Debt) in the Australian market.

Justine leads the investment team for the Victorian Growth Fund. She is responsible for identifying and assessing potential investments, promoting the Fund and managing the partnership with the Victorian Government and other stakeholders. She is passionate about investing in startups and growth companies generating jobs and innovation for Victoria and broader Australia, and pursuing ideas that will benefit Australians.

Justine holds a Bachelor of Commerce from the University of Melbourne, majoring in Accounting and Finance. Justine is a Chartered Accountant and Chartered Financial Analyst. In her spare time, she has pursued qualifications in viticulture and wine, and recently completed Wine & Spirits Education Trust – Level II in Wine.

|   Growth Equity 

|   Location: Sydney, AU

Jay identifies and analyses growth equity investment opportunities while supporting portfolio companies with research, strategic planning and problem-solving to help them scale into new markets.

He collaborates with CFOs and leadership teams to simplify financial complexities and drive growth and serves as a Board Observer for Lumary, Kepler Analytics and Flippa.

With over 15 years of global equities experience specialising in high-conviction, long-term growth strategies, Jay began his career as a software engineer, and has held roles in risk modelling, portfolio management and public equities focused on technology at CITIC Securities (HK), HSBC (UK, HK), and Goldman Sachs (UK). He was also a buy-side investment analyst for a boutique global equities fund manager.

Jay holds a Bachelor of Engineering (Hons) in Software and a Master of Commerce in Finance from the University of New South Wales

|   B. Eng (Hons), M. Com (Finance)

|   Growth Credit   

|   Location: Sydney, AU

|   Growth Credit

|   Location: Sydney, AU

Ryan is an Investment Manager on our Growth Credit team and is responsible for deal sourcing, evaluating opportunities, executing transactions and assisting portfolio companies in scaling and securing follow-on funding where appropriate.

He has worked on deals with companies such as Cascade and Biza.

Previously, Ryan worked at Wayflyer, a venture-backed fintech scale-up providing revenue-based financing to eCommerce brands. He led business operations and new product development, helping scale the company from 30 to 300 employees. Before that, he advised consumer goods and financial services clients as a consultant with McKinsey & Company.

Ryan holds a Bachelor of Science in Economics and Finance from University College Dublin.

|   B.Sc. Economics & Finance

|   Growth Equity

|   Location: Sydney, AU

Matt focuses on growth equity investments in technology businesses for Fund V and Fund VII.

He supports deal sourcing, analysis and due diligence and works with portfolio companies like Lumary, Flippa and Buildkite.

Since joining OneVentures in 2021, Matt has contributed to both the venture credit and equity teams. Now an Investment Associate, he has played a key role in sourcing and executing growth equity investments.

Before OneVentures, Matt gained experience at MA Financial Group, Perpetual and VGI Partners, focusing on technology investing, ESG and company analysis.

He holds a Bachelor of Commerce and a Bachelor of Advanced Studies from the University of Sydney, where he received the University Academic Merit Prize. He earned a Master’s in Neuroscience from the University of Sydney, completing a thesis on using “digital twins” to augment operational decision-making in complex systems such as mental health clinics.

|   BCom/BAdvStudies/MSci

|   Growth Equity

|   Location: Sydney, AU

Joanna focuses on Growth Equity investments, supporting deal sourcing, analysis, due diligence and monitoring portfolio investments

She works closely with portfolio companies, including Employment Hero, Lumary and Flippa.

Before joining OneVentures, Joanna was a consultant at McKinsey & Company’s Melbourne office, where she worked on strategic and operational projects in the banking, consumer goods, and automotive sectors for public and private clients. She gained international experience in Singapore with Wavemaker Impact, a leading Asian ClimaTech VC venture builder, where she helped develop an AgriTech startup aimed at reducing the carbon footprint of Southeast Asian rice cultivation by assessing opportunities and designing viable business models.

Joanna holds a Bachelor of Laws and Commerce (Finance) from Monash University and a Master’s in Management from INSEAD. She is admitted to the Supreme Court of Victoria and previously practiced law in the private health insurance sector at the Australian Prudential Regulatory Authority.

|    LL.B., BComm (Finance), MIM

|   PhD, Pathobiology   |   Location: Sydney, AU

Dr Lu Li is an investment analyst in OneVentures’ Healthcare team.

Lu supports the Healthcare team by performing quantitative and qualitative research to inform investment, valuation and exit decisions. Lu also assists with deal screening and performing due diligence whilst also reporting and monitoring existing and prospective fund investments.

Lu regularly practices meditation and loves to study herbal medicine. She also paints and sketches in her free time.

Lu brings over 7 years of biomedical research experience in academia to the OneVentures team. She has a strong technical background on research & development in general, and always follows the latest research progress.

In addition, Lu brings her depth of experience for financial modelling and equity research, along with her keen interest in finance.

Prior to joining with OneVentures, Lu joined CITIC’s Biotech Equity Research area as an intern. She later worked as a scientific writer and technical consultant at DeepTech, a new media platform, where she covers biotech startups and latest biomedical research, and simultaneously completed level 2 of the CFA.

Lu received her Ph.D in Pathobiology from the University of Connecticut in the US, where she focused her research on infectious disease pathogenesis.

|   Growth Credit  

|   Location: Melbourne, AU

Shawn plays a key role in the Growth Credit team, contributing across the entire deal cycle through portfolio analysis, due diligence and guiding transactions at every stage.

Before joining OneVentures, Shawn worked in the strategy team at Accenture, focusing on growth, decarbonisation, M&A and technology. Prior to that, he worked at Uber as an Operations Associate, managing consumer behaviour and lifecycle across the Rides, Eats and CommOps teams.

Shawn holds a Bachelor of Commerce from the University of Melbourne, majoring in Economics and Finance. He represented his university in international case competitions in Norway and Thailand, providing strategic advice to multinational companies.

|   BCom (Economics & Finance)

|   Location: Sydney, AU

|   CA, BaCom (Accounting and Finance)

|   Location: Sydney, AU

Lenny supports the finance, reporting, accounting and operations functions across OneVentures’ investment entities.

With over 10 years of experience in financial reporting, management reporting, statutory reporting and fund administration, Lenny has held finance roles in both listed and unlisted fund managers, as well as in fund administration and financial services companies

He holds a Bachelor of Commerce in Accounting and Finance from the University of New South Wales and a Master of Economics from Macquarie University. Lenny is a member of CPA Australia

|   BCom / Master of Economics .

|   Location: Sydney, AU

Justin supports client and investor reporting, regulatory reporting, NAV calculations, unit pricing, fund accounting and trust distribution.

His career began in Singapore before moving to Australia in 2009, where he transitioned into finance and accounting. Justin has held positions at IOOF, Link Group, MLC, and, most recently, Unity Fund Services. His extensive experience spans various facets of financial operations, including client reporting, investor reporting, regulatory compliance and fund administration.

Justin holds a Master of Applied Finance from Macquarie University and a Bachelor of Arts from the National University of Singapore. He is a CPA (Certified Practising Accountant) and a recipient of the Certificate of Excellence.

|   CPA, Master of Applied Finance, Bachelor of Arts 

|   Location: Sydney, AU

Jill manages OneVentures corporate finance function, covering accounting, taxation, corporate secretarial duties, internal controls and business insurances. She supports the Risk Management Committee and oversees outsourced IT support and HR administration, including onboarding, offboarding and employment contracts.

With a career spanning corporate tax, commercial accounting and corporate finance, Jill successfully managed a merger of her own accounting business. She previously worked in corporate tax at KPMG for six years and in corporate finance with Moody’s Investors Service for three years.

Jill holds a Bachelor of Economics from the University of New South Wales and is a member of Chartered Accountants Australia and New Zealand.

|   BEc, CA 

|   Location: Sydney, AU

Heather Maini is the team coordinator for OneVentures, having built a long and successful career in office administration.

She brings nearly 20 years’ of experience in client service and office management to the OneVentures team, and provides essential support for both the investment and operations teams.

|   SC 2001, Business Administration Certificate V 2002 

|   MEng (Engineering)  |   Location: Melbourne, AU

Chris is Head of Distribution at OneVentures, overseeing the firm’s fundraising and investor relations activities.

Chris brings over 25 years of sales experience in financial services across Australia and Europe. He has worked closely with institutional and wealth clients across a diverse range of asset classes spanning both private and public markets. This has given him valuable insight into clients’ portfolio construction needs, and he is passionate about delivering solutions that address them.

Before joining OneVentures, Chris was Managing Director, Business Development at Pacific Current Group, where he worked with several of the company’s globally based affiliated fund managers on distribution in the APAC region. Prior to that, he led Nikko AM’s Institutional Business in Australia.

Chris spent 10 years at Goldman Sachs, starting in fixed income credit sales in the UK, later moving to Australia and focusing on funds management distribution.

Chris holds a Meng degree in Engineering from Cambridge University and serves on the Cambridge Australia Scholarships Investment Committee.

|   BA HR & Industrial Relations, Grad. Cert. Finance, Dip. Financial Planning   |   Location: Sydney, AU

Maria Baas is the Investor Relations Director at OneVentures. She is responsible for developing, managing investor relationships and implementing Investor Relations strategy and helping to build out the firm’s Investor Relations capability in the Australian market.

Maria joined the team from Macquarie Group where she was developing strategic relationships with external stakeholders in the Corporate and Asset Finance division. Prior to that Maria worked at UBS Asset Management where she was responsible for key client relationship management and institutional business development across industry super funds, insurance firms, large corporates and consultants. Maria also held various roles in financial planning and funds management with AMP Capital and AMP Limited more broadly. She started her career in HNW boutique wealth management firm as the Client Relationship Manager.

Maria holds a Bachelors Degree in HR and Industrial Relations from the University of Sydney. Additionally, she has completed a Graduate Certificate of Finance at Macquarie University and a Diploma of Financial Planning.

|   Location: Sydney, AU

Rhianna leads marketing, PR, community and branding initiatives at OneVentures, developing strategies to enhance the firm’s visibility and reputation within the venture capital ecosystem. She manages initiatives to foster connections among founders, entrepreneurs and industry stakeholders.

Before moving to Australia in 2022, Rhianna worked in the European tech ecosystem in London. She managed a community of women in tech, led a global women in STEM awards program and contributed to London Tech Wee alongside supporting climate, health and early-stage founder communities.

Passionate about creating meaningful connections and opportunities for engagement, Rhianna leverages her global experience to strengthen the Australian VC landscape. She is dedicated to growing the OneVentures community with a focus on technology and venture credit, supporting founders and funders in driving innovation and growth.

In addition to her role at OneVentures, Rhianna is the CEO of WinVC, a non-profit women-led initiative co-founded by Dr Michelle Deaker. WinVC is a learning and knowledge sharing program that focuses on supporting the career trajectory of women investors in venture capital.

Rhianna holds a Bachelor of Science from Royal Holloway, University of London.

|   Royal Holloway, University of London

|   Location: Sydney, AU

Abbie coordinates OneVentures’ marketing, PR, community and branding initiatives, strengthening the firm’s identity and amplifying the visibility of our portfolio companies.

Before joining OneVentures, Abbie worked at 89up in London, Europe’s first impact PR agency, where she contributed to global campaigns for NGOs.

|   BA(Hons) 

Mr Lewin is Chair of the Board and Investment Committee for OneVentures Pty Ltd. He is a member of the Advisory Board of VGI Partners, a leading global investment firm based in Sydney and New York. Mr Lewin was a founding shareholding and Chair of the Advisory Board of OneVue (ASX: OVH) and was a founding shareholder and Executive Director of Reverse Corp (ASX: REF). Previously, he was a Managing Director of Ord Minnett and member of its Group Management Committee, a Principal of Elysium Capital Partners in London, a Managing Director (Equities) for Merrill Lynch in London after holding several positions in the Equities and Investment Banking divisions of SBC (now UBS) in London and SBC Dominguez Barry (now UBS) in Sydney.

Mr Lewin received a Bachelor of Commerce (First Class Honours) and a Bachelor of Laws (Honours) from University of Queensland. He was a visiting lecturer in business finance at the Queensland Institute of Technology. He received the Baillieu Research award in 1989.

Peter Gammell is currently the Executive Chairman of Invictus Advisory Pty Ltd and Non-Executive Chairman of Octet Finance Pty Ltd. Prior to this role he was Chief Executive Officer of Seven Group Holdings and Deputy Chairman of Australian Capital Equity Pty Ltd (ACE), the Western Australian based holding company associated with Mr. Kerry Stokes. He was the Managing Director of ACE for 21 years which is now one of Australia’s largest private companies.

He has served as a Director of Seven Network Ltd, RM Williams Ltd, National Hire Ltd, Consolidated Media Holdings Ltd and was the Chairman of Coates Hire. He led the creation of the Seven Media Group, a joint venture between Seven Network Limited and the private equity firm Kohlberg Kravis Roberts & Co. in 2006. In June 2010 Mr Gammell was appointed the Chief Executive Officer of Seven Group Holdings Limited, a public company listed on the Australian Stock Exchange which was formed as a result of the merger of Seven Network Limited and WesTrac Holdings Pty Ltd.

He currently serves as a Director of Seven West Media Limited (formed in 2011 by the merger of West Australian Newspapers Holdings with Seven Media Group), is a Director of Thinksmart Ltd, a UK based consumer finance company which is listed on AIM in London, and in January 2018, joined the Board of Directors of OneVentures Pty Ltd.

During Peter’s career he has been instrumental in acquiring and building multi-billion dollar enterprises with in excess of $10 billion of mergers and acquisitions.

Mr Gammell is a member of the Institute of Chartered Accountants of Scotland and holds a Bachelor of Science degree from the University of Edinburgh.

Roger is a director of OneVentures Pty Ltd, a technology venture capital firm, and is the principal shareholder and director of Eureka Capital Partners, a private investment concern. He is also a director of Illawarra Coke Company, an industrial land development concern.

Mr Massy-Greene previously served as the Chair of Ausgrid, Endeavour Energy and Essential Energy, having been appointed by the NSW government in 2012 to oversee reform of the NSW electricity distribution sector.

He previously co-founded the ASX 200 company Excel Coal Limited and its predecessor Resource Finance Corporation Ltd, and served as Chair of Excel Coal until its acquisition by Peabody Energy in 2006.

Mr Massy-Greene serves as Chair of Eureka Benevolent Foundation, a family foundation focused on overcoming socio-economic disadvantage.  He is the President of Cranbrook School and a director of The Hunger Project in the USA and Australia.

|   Location: Sydney, AU

Dr Michelle Deaker is a Founding & Managing Partner of OneVentures and has been primarily responsible for the foundation of OneVentures firm and capital raisings of OneVentures Funds. The firm now has over $700M in funds under management. Michelle serves on the investment committee of OneVentures three main Funds, leads the technology practice within the firm and is responsible for investor relations managing the supervisory boards of OneVentures funds.

Michelle has over 20 years experience in the development of high growth technology companies in Australia and the US, has served on the boards of large and small listed and unlisted companies and has a strong background in Australian R&D and expertise in global business expansion. She has negotiated technology transfer contracts with research institutions; established financing syndicates with Australian, Asian and US investors; chaired the boards of several high growth companies; supported early breakthrough commercial contracts; leveraged her extensive networks for the benefit of OneVentures companies; and negotiated both financing and exit transactions.

Michelle established OneVentures in late 2006, coming into the venture capital industry as a successful IT industry business owner, entrepreneur and subsequently angel investor. The Company she founded in 1999, E Com Industries (www.giftvouchers.com), became the leading prepaid card and electronic voucher provider in Australia, servicing over 100 major retail brands including Coles Myer and Woolworths, managing $700M in Australian retail liability and eventually expanding operations into the United Kingdom, South Africa and New Zealand. E Com was acquired by UK publicly listed company, Retail Decisions, in 2005, in a transaction returning to investors 4.6x capital and an average IRR of 70%. Notably, E Com industries was one of only a handful of Australian companies that successfully migrated the dotcom boom and crash through to a successful outcome for investors. Prior to E Com Industries, Michelle established IT enterprise business, Networks Beyond 2000.

Michelle holds a Bachelor of Science (Honours 1st class), Master of Science and a PhD (Applied Science). She is a member of the Australian Institute of Company Directors and Chief Executive Women (CEW).

|   BSc(Hons), MSc, PhD 

|   Healthcare  

|   Location: Sydney, AU

Paul is a Founding Partner of OneVentures, leading the Healthcare and Biotechnology practice. He serves as Fund Lead and Chair of the Investment Committee for Healthcare Fund III and is a voting member of the Investment Committees for Funds I, II, III and V.

With over 30 years of experience in biomedical innovation, Paul provides strategic guidance to portfolio companies. He is Chair of Vaxxas and a Non-Executive Director for BiVACOR and Prota Therapeutics. Previously, he served on the boards of Hatchtech (Chair, licensed to NYSE: DRL), CharmHealth (acquired by ASX: CGL), Clinical Genomics (Enterix acquired by 3TM), Blade and Find Me.

As co-founder of Gemini Genomics (Nasdaq: GMNI), he led one of the UK’s largest biotech IPOs (US$250M valuation) before its merger with Sequenom (Nasdaq: SQNM). Earlier in his career, he co-founded Agamatrix, a bio-sensing medical device company operating in the US and Southeast Asia as well as Atomera (Nasdaq: ATMR). As CEO of Orchid Cellmark (Nasdaq: ORCH), he drove a tenfold valuation increase and significant revenue growth.

Paul began his career as a researcher and endocrinologist at St Vincent’s Hospital Sydney before transitioning into biotechnology. In the US, he held executive roles in leading biotech and medical companies driving the growth of several industry leaders.

He has authored over 100 publications in leading journals and is a Non-Executive Director at the Garvan Institute of Medical Research, a member of the UNSW Medicine Dean’s Advisory Group and serves on the Advisory Board of the Australian Government’s Australia’s Economic Accelerator (AEA) program.

Paul holds medical degrees from UNSW and is a Fellow of the Royal Australasian College of Physicians.

|   MBBS(Hons), MD, FRACP 

|   Location: Brisbane, AU

|   BSc(Hons), MBA, GAICD 

|   BSc(Hons), AMCT   |   Location: Sydney, AU

Nick Gainsley is a Partner at OneVentures and leads the Growth Credit practice of the firm. Nick is committed to ensuring that companies in Australia can access alternative forms of capital by bringing his extensive global experience with debt and financing to the local market.

As one of the leading pioneers of Growth Credit in Australia, Nick is in high demand as a keynote speaker and conference panellist. He regularly appears in the media as an expert on Growth Credit and alternative debt financing. For media and speaking enquiries, please contact us.

Nick is a keen skier and loves to travel the world – with his young family in tow. Being a Brit he used to long haul and is looking forward to the direct Sydney-London flight in the coming years. He loves to ski steep off-piste terrain however he’s been forced to recalibrate to “family friendly” black runs.

Nick brings over 15 years of debt experience both in direct lending and advisory, in Europe and Australia. He has nearly 10 years of Growth Credit experience having led investments to over 100 high growth technology companies across 11 countries.

At OneVentures, he serves on the Investment Committee of the 1V Venture Credit Fund IV and the OneVentures Growth Fund V.

Prior to joining OneVentures in May 2019, Nick was based in the UK and was a Principal at Kreos Capital (now part of Blackrock), Europe’s largest growth debt fund. His experience there covered deal origination, execution and portfolio management for a significant number of transactions across European markets. He has wider sector experience across technology sub-sectors including FinTech, software, cyber security, hardware, e-commerce/DTC, AdTech and life science, investing in both private and public companies.

Prior to this Nick was a Manager at KPMG in London within its Debt Advisory team, where he was involved in managing and advising on a range of debt transactions from mid-market to large cap. Transaction experience covered leveraged finance, corporate refinancing, capital market issuance and strategic financing advice.

Nick is currently a mentor at Stone & Chalk and the AIC women mentorship programme.